|
|
 |
|
Viewing report
|
|
|
|
Autoimmune and Inflammation - Lupus Drug Pipeline Report
Life Science Analytics, June 2007, Pages: 18
Life Science Analytics, 'Autoimmune and Inflammation - Lupus Drug Pipeline Report' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of lupus drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
- Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company’s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.
Customers who bought this item also bought
Autoimmune And Inflammation Lupus
Systemic Lupus Erythematosus Imprecise Segmentation Complicates Treatment Algorithms
Stakeholder Opinions: Systemic Lupus Erythematosus - Market Set to Enter Era of Biologic Therapies
Commercial Insight: Autoimmune Overview - Market continues to prosper
Autoimmune/Inflammatory Disease: Competitive Strategies - Competitive Analysis, Profiles, and Portfolio Strategies of the Top Autoimmune/Inflammatory Therapeutic Manufacturers in the US (2001 Edition)
Autoimmune/Inflammatory Disease Drug Licensing Opportunities: Analysis, Rating and Ranking - A Worldwide Study
Competitor Analysis: CD20 Antibodies
Immunomodulators: Therapeutic Needs, Pipelines & Prospects
Multiplexed Diagnostics 2009 Market Report
Dendritic Cells: Targets for Immunotherapy
Biomarkers - Technologies, Markets and Companies
Current Drug Development Market for Cytokines, Chemokines and Growth Factors
|
|
|
|
